¾È³çÇϼ¼¿ä?
2018³â 3¿ùÈ£¿¡ ¹ßÇàµÇ¾ú´ø ¾Æ·¡ÀÇ ³í¹®À» Ÿ ÇмúÁö Áߺ¹°ÔÀç »çÀ¯·Î ÀÎÇØ °ÔÀçöȸ ÇÏ¿´À½À» ¾Ë·Á µå¸³´Ï´Ù.
ÇØ´ç ³í¹®¿¡ ´ëÇÑ retractionÀº ´ÙÀ½È£ÀÎ 2018³â 6¿ùÈ£¿¡ ÷ºÎ ÆÄÀÏ°ú °°ÀÌ ¹ßÇà µÇ¾ú½À´Ï´Ù.
ÇâÈÄ ÀÌ·¯ÇÑ Áߺ¹°ÔÀç, ¶Ç´Â ¿¬±¸À±¸®À§¹ÝÀ¸·Î ÀÎÇÑ °ÔÀçöȸ »çÀ¯ ¹ß»ý ½Ã Blood Research¿¡ 3³â°£ ³í¹® Åõ°í¸¦ ÇÒ ¼ö ¾ø»ç¿À´Ï Âü°í ºÎŹ µå¸³´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
= ¾Æ ·¡ =
¡Ü ¹ßÇà³âµµ: 2018³â 6¿ùÈ£(Blood Res 2018;53(1):87-89)
¡Ü ³í¹®ÀúÀÚ: Appalanaidu Sasapu1, Dinesh Atwal1, Giovanni Insuasti-Beltran2, Yogesh Jethava3
1Department of Internal Medicine, Division of Hematology, 2Department of Pathology and Laboratory Medicine, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, 3Department of Internal Medicine, Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa, Iowa City, IA, USA
¡Ü ³í¹®Á¦¸ñ: Primary CNS high-grade B-cell lymphoma, with rearrangements of MYC and BCL6 : a case report